other material
confidence high
sentiment negative
materiality 0.90
Gamida Cell Ltd.: Nasdaq/NYSE listing notice — Gamida Cell receives Nasdaq delisting notice; restructuring plan cancels all existing shares
Gamida Cell Ltd.
- Nasdaq notified Gamida Cell on March 28, 2024, that shares will be delisted due to restructuring; trading suspended April 8; no appeal.
- Restructuring converts $75M unsecured debt from Highbridge funds into 100% of company shares, cancelling all existing shares and options.
- Existing shareholders may receive up to $27.5M in contingent value rights (CVRs) based on Omisirge revenue milestones and NK platform approval.
- Lender will provide $50M exit financing: $30M on closing, plus conversion of ~$5M existing secured debt and $15M later.
- Company will become private and deregister with SEC following court approval of creditors' arrangement.